Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2006-04-11
2006-04-11
Epps-Ford, Janet L. (Department: 1633)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C514S04400A, C435S455000, C435S458000
Reexamination Certificate
active
07025987
ABSTRACT:
αvβ3Integrin receptor targeting liposomes comprise a cationic amphiphile such as a cationic lipid, a neutral lipid, and a targeting lipid. The targeting lipid includes a non-peptidic αvβ3integrin antagonist.
REFERENCES:
patent: 4897355 (1990-01-01), Eppstein et al.
patent: 5741796 (1998-04-01), Hartman et al.
patent: 6066123 (2000-05-01), Li et al.
patent: 6372250 (2002-04-01), Pardridge
patent: 6458026 (2002-10-01), Hart
patent: 6521211 (2003-02-01), Unger et al.
patent: 2002/0071843 (2002-06-01), Li et al.
patent: 2002/0172711 (2002-11-01), Martin et al.
patent: 2003/0203865 (2003-10-01), Harvie et al.
patent: WO 98/35949 (1998-08-01), None
patent: WO 00/26212 (2000-05-01), None
Storrs et al; “Paramagnetic Polymerized Liposomes: Synthesis, Characterization, and Applications for Magnetic Resonance Imaging” J. Am. Chem. Soc., 117, pp. 7301-7306 (1995).
Sipkins et al. “Detection of tumor angiogensis in vivo by α, β,-targeted magnetic resonance imaging” Nature Medicine, 4, pp. 623-626 (1998).
Wong et al. “Cationic Lipid Binding to DNA: Characterization of Complex Formation” Biochemistry, 35, pp 5756-5763 (1996).
Cooper et al. “Peptide Mini-Vectors for Gene Delivery” Angew. Chem. Int. Ed., 38, pp 1949-1952 (1999).
Li et al. “Efficient Gene Delivery to Vascular Smooth Muscle Cells Using a Nontoxic, Synthetic Peptide Vector System Targeted to Membrane Integrins: A First Step Toward The Gene Therapy of Chronic Rejection” Transplantation, 70, pp 1616-1624 (2000).
Miller “Cationic Liposomes for Gene Therapy” Angew. Chem. Int. Ed., 37, pp 1769-1785 (1998).
Cooper et al. “Polyamine Analogues of 3β-[N-(N′-N′-Dimethylaminoethane)carbamoyl]-cholesterol (DC-Chol) as Agents for Gene Delivery” Chem. Eur. J., 4, pp 137-151 (1998).
Düffels, et al. “Synthesis of High-Mannose Type Neoglycolipids: Active Targeting of Liposomes to Macrophages in Gene Therapy” Chem. Eur. J., 6, pp 1416-1430 (2000).
Reimer et al. “Formation of Novel Hydrophobic Complexes between Cationic Lipids and Plasmid DNA” Biochemistry, 34, pp 12877-12883 (1995).
Monnard et al. “Entrapment of nucleic acids in liposomes” Biochem. Biophys. Acta, pp 39-50 (1997).
Website of Andrew Miller Research Group at http://www.gtc.ch.ic.ac.uk/miller/catlips. html, accessed on May 13, 2002 “Design, synthesis and testing of non-viral vectors for direct use in gene therapy” and accompanying pdf document entitled “Case History A little bit of lipid helps the medicine go down” hyperlinked thereto.
Xiong et al. “Crystal Structure of the Exrtracellular Segment of Integrin αVβ3 in Complex with an Arg-Gly-Asp Ligand” Science, 296, pp 151-155 (2002).
Bednarski Mark
Cheresh David A.
Hood John
Board of Trustees of The Leland Stanford Jr. University
Epps-Ford Janet L.
Olson & Hierl Ltd.
The Scripps Research Institute
LandOfFree
Delivery system for nucleic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Delivery system for nucleic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delivery system for nucleic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3599930